Nutrigenomics and inflammatory bowel diseases

References

• Afman L, Muller M. Nutrigenomics: from molecular nutrition to prevention of disease. J. Am. Diet Assoc.106(4), 569–576 (2006).
   PubMedGoogle Scholar
• Ekbom A. Twin studies in IBD and other disorders. J. Pediatr. Gastroenterol. Nutr.46(Suppl. 1), E9 (2008).
   Google Scholar
• Woolner JT, Parker TJ, Kirby GA, Hunter JO. The development and evaluation of a diet for maintaining remission in Crohn’s disease. J. Hum. Nutr. Diet.11(1), 1–11 (1998).
   Google Scholar
• Baker PI, Love DR, Ferguson LR. Role of gut microbiota in Crohn’s disease. Expert Rev. Gastroenterol. Hepatol.3(5), 535–546 (2009).
   PubMedGoogle Scholar
• Jowett SL, Seal CJ, Pearce MS et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut53(10), 1479–1484 (2004).
   PubMed Web of Science ®Google Scholar
• Petermann I, Triggs CM, Huebner C et al. Mushroom intolerance: a novel diet–gene interaction in Crohn’s disease. Br. J. Nutr.102(4), 506–508 (2009).
   PubMed Web of Science ®Google Scholar
• Barnett M, Bermingham E, McNabb W et al. Investigating micronutrients and epigenetic mechanisms in relation to inflammatory bowel disease. Mutat. Res. DOI: 10.1016/j.mrfmmm.2010.02.006 (2010) (In Press).
   Google Scholar
• van Limbergen J, Wilson DC, Satsangi J. The genetics of Crohn’s disease. Annu. Rev. Genomics Hum. Genet.10, 89–116 (2009).
   PubMed Web of Science ®Google Scholar
• Ferguson LR, Philpott M, Dryland P. Nutrigenomics in the whole-genome scanning era: Crohn’s disease as example. Cell. Mol. Life Sci.64(23), 3105–3118 (2007).
   PubMedGoogle Scholar
• Mathews C. New links to the pathogenesis of Crohn disease provided by genome-wide association scans. Nat. Rev. Genet.9(1), 9–14 (2008).
   PubMedGoogle Scholar
• Kugathasan S, Baldassano RN, Bradfield JP et al. Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat. Genet.40(10), 1211–1215 (2008).
   PubMed Web of Science ®Google Scholar
• Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature411(6837), 599–603 (2001).
   PubMed Web of Science ®Google Scholar
• Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature411(6837), 603–606 (2001).
   PubMed Web of Science ®Google Scholar
• Girardin SE, Boneca, IG, Viala J et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem.278(11), 8869–8872 (2003).
   PubMed Web of Science ®Google Scholar
• Gearry RB, Richardson A, Frampton C et al. High incidence of Crohn’s disease in Canterbury, New Zealand: results of an epidemiologic study. Inflamm. Bowel Dis.12(10), 936–943 (2006).
   PubMed Web of Science ®Google Scholar
• Hugot JP. CARD15/NOD2 mutations in Crohn’s disease. Ann. NY Acad. Sci.1072(1), 9–18 (2006).
   PubMed Web of Science ®Google Scholar
• Philpott M, Mackay L, Ferguson LR, Forbes D, Skinner M. Cell culture models in developing nutrigenomics foods for inflammatory bowel disease. Mutation Res.622(1–2), 94–102 (2007).
   PubMed Web of Science ®Google Scholar
• Huebner C, Ferguson LR, Han DY et al. Nucleotide-binding oligomerization domain containing 1 (NOD1) haplotypes and single nucleotide polymorphisms modify susceptibility to inflammatory bowel diseases in a New Zealand Caucasian population: a case–control study. BMC Res. Notes2, 52 (2009).
   PubMedGoogle Scholar
• Arbour NC, Lorenz E, Schutte BC et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet.25(2), 187–191 (2000).
   PubMed Web of Science ®Google Scholar
• Browning B, Huebner C, Petermann I et al. Has Toll-like receptor 4 been prematurely rejected as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association. Am. J. Gastroenterol.102(11), 2504–2512 (2007).
   PubMed Web of Science ®Google Scholar
• Ferguson L, Browning BL, Huebner C et al. Single nucleotide polymorphisms in human Paneth cell defensin A5 may confer susceptibility to inflammatory bowel disease in a New Zealand Caucasian population. Dig. Liver Dis.40(9), 723–730 (2008).
   PubMedGoogle Scholar
• Petermann I, Huebner C, Browning BL et al. Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort. Hum. Immunol.70(6), 440–446 (2009).
   PubMed Web of Science ®Google Scholar
• Rioux JD, Ramnik JX, Taylor KD et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet.39(5), 596–604 (2007).
   PubMed Web of Science ®Google Scholar
• Hampe J, Franke A, Rosenstiel P et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet.39(2), 207–211 (2007).
   PubMed Web of Science ®Google Scholar
• Reis E, Sousa C. Immunology: eating in to avoid infection. Science315(5817), 1376–1377 (2007).
   PubMedGoogle Scholar
• Lee HK, Lund JM, Ramanathan B, Mizushima N, Iwasaki A. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science315(5817), 1398–1401 (2007).
   PubMed Web of Science ®Google Scholar
• Mizushima N, Klionsky D. Protein turnover via autophagy: implications for metabolism. Annu. Rev. Nutr.27, 19–40 (2007).
   PubMed Web of Science ®Google Scholar
• Sinsimer D, Fallows D, Peixoto B, Krahenbuhl J, Kaplan G, Manca C. Mycobacterium leprae actively modulates the cytokine response in naive human monocytes. Infect. Immun.78(1), 293–300 (2010).
   PubMed Web of Science ®Google Scholar
• Travassos L, Carneiro LA, Girardin S, Philpott DJ. Nod proteins link bacterial sensing and autophagy. Autophagy6(3), 409–411 (2010).
   PubMed Web of Science ®Google Scholar
• Travassos L, Carneiro LA, Ramjeet M et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat. Immunol.11(1), 55–62 (2010).
   PubMed Web of Science ®Google Scholar
• Cooney R, Baker J, Brain O et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat. Med.16(1), 90–97 (2010).
   PubMed Web of Science ®Google Scholar
• Duerr RH, Taylor KD, Brant SR et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science314(5804), 1461–1463 (2006).
   PubMed Web of Science ®Google Scholar
• Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature448(7152), 427–434 (2007).
   PubMed Web of Science ®Google Scholar
• Barrett JC, Hansoul S, Nicolae DL et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat. Genet.40(8), 955–962 (2008).
   PubMed Web of Science ®Google Scholar
• Ferguson L, Han DY, Fraser AG et al. Genetic factors in chronic inflammation: single nucleotide polymorphisms in the STAT–JAK pathway, susceptibility to DNA damage and Crohn’s disease in a New Zealand population. Mutat. Res. (2010) DOI: 10.1016/j.mrfmmm.2010.01.017 (Epub ahead of print).
   Google Scholar
• Ferguson LR, Huebner C, Petermann I et al. Single nucleotide polymorphism in the tumor necrosis factor-α gene affects inflammatory bowel diseases risk. World J. Gastroenterol.14(29), 4652–4661 (2008).
   PubMedGoogle Scholar
• Fisher SA, Tremelling M, Anderson CA et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn’s disease. Nat. Genet.40(6), 710–712 (2008).
   PubMed Web of Science ®Google Scholar
• Fernando MM, Stevens CR, Walsh EC et al. Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genetics.4(4), e1000024 (2008).
   PubMed Web of Science ®Google Scholar
• Wang S, Raven JF, Baltzis D et al. The catalytic activity of the eukaryotic initiation factor-2 α kinase PKR is required to negatively regulate Stat1 and Stat3 via activation of the T-cell protein-tyrosine phosphatase. J. Biol. Chem.281, 9439–9449 (2006).
   PubMed Web of Science ®Google Scholar
• Lu X, Chen J, Sasmono RT et al. T-cell protein tyrosine phosphatase, distinctively expressed in activated-B-cell-like diffuse large B-cell lymphomas, is the nuclear phosphatase of STAT6. Mol. Cell. Biol.27(6), 2166–2179 (2007).
   PubMed Web of Science ®Google Scholar
• Amre DK, Mack DR, Morgan K et al. Investigation of reported associations between the 20q13 and 21q22 loci and pediatric-onset Crohn’s disease in Canadian children. Am. J. Gastroenterol.140(11), 2824–2828 (2009).
   Google Scholar
• Glocker E, Kotlarz D, Boztug K et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med.361(21), 2033–2045 (2009).
   PubMed Web of Science ®Google Scholar
• Goyette P, Lefebvre C, Ng A et al. Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis. Mucosal Immunol.1(2), 131–138 (2008).
   PubMed Web of Science ®Google Scholar
• Peltekova VD, Wintle RF, Rubin LA et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet.36(5), 471–475 (2004).
   PubMed Web of Science ®Google Scholar
• Ferguson L, Han DY, Huebner C et al. Single nucleotide polymorphisms in IL4, OCTN1 and OCTN2 genes in association with inflammatory bowel disease phenotypes in a Caucasian population in Canterbury, New Zealand. The Open Gastroenterology Journal2(7), 50–56 (2008).
   Google Scholar
• Stoll M, Corneliussen B, Costello CM et al. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat. Genet.36(5), 476–480 (2004).
   PubMed Web of Science ®Google Scholar
• Browning B, Annese V, Barclay ML et al. Gender-stratified analysis of DLG5 R30Q in 4707 Crohn’s disease patients and 4973 controls from 12 Caucasian cohorts. J. Med.Genet.45, 36–42 (2008).
   PubMedGoogle Scholar
• Festen EA, Stokkers PC, van Diemen CC et al. Genetic analysis in a Dutch study sample identifies more ulcerative colitis susceptibility loci and shows their additive role in disease risk. Am. J. Gastroenterol.105(2), 395–402 (2010).
   PubMed Web of Science ®Google Scholar
• Franke A, Balschun T, Karlsen TH et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat. Genet.40(11), 1319–1323 (2008).
   PubMed Web of Science ®Google Scholar
• Glas J, Stallhofer J, Ripke S et al. Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease. Am. J. Gastroenterol.104(7), 1737–1744 (2009).
   PubMedGoogle Scholar
• Huebner C, Petermann I, Browning BL et al. Genetic association study of MDR1 and inflammatory bowel disease reveals partial protective effect of heterozygous variants in ulcerative colitis. Inflamm. Bowel Dis.15(12), 1784–1793 (2009).
   PubMed Web of Science ®Google Scholar
• Juyal G, Midha V, Amre D, Sood A, Seidman E, Thelma BK. Associations between common variants in the MDR1 (ABCB1) gene and ulcerative colitis among North Indians. Pharmacogenet. Genomics19(1), 77–85 (2009).
   PubMed Web of Science ®Google Scholar
• Lees CW, Satsangi J. Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history. Expert Rev. Gastroenterol. Hepatol.3(5), 513–534 (2009).
   PubMedGoogle Scholar
• Lee G, Buchman AL. DNA-driven nutritional therapy of inflammatory bowel disease. Nutrition25(9), 885–891 (2009).
   PubMed Web of Science ®Google Scholar
• Stardelova G, Misevska P, Zdravkovska M, Trajkov D, Serafimoski V. Total parenteral nutrition in treatment of patients with inflammatory bowel disease. Prilozi29(1), 21–43 (2008).
   PubMedGoogle Scholar
• Geerling B, Badart-Smook A, Stockbrugger RW, Brummer RJ. Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls. Eur. J. Clin. Nutr.54(6), 514–521 (2000).
   PubMed Web of Science ®Google Scholar
• Geerling BJ, Dagnelie PC, Badart-Smook A, Russel MG, Stockbrügger RW, Brummer R. Diet as a risk factor for the development of ulcerative colitis. Am. J. Gastroenterol.95(4), 1008–1013 (2000).
   PubMed Web of Science ®Google Scholar
• Russel MG, Engels LG, Muris JW et al. Modern life in the epidemiology of inflammatory bowel disease: a case–control study with special emphasis on nutritional factors. Eur. J. Gastroenterol. Hepatol.10(3), 243–249 (1998).
   PubMedGoogle Scholar
• Triggs C, Munday K, Hu R et al. Dietary factors in chronic inflammation: food tolerances and intolerances of a New Zealand Caucasian Crohn’s disease population. Mutat. Res. DOI: 10.1016/j.mrfmmm.2010.01.020 (2010) (Epub ahead of print).
   PubMedGoogle Scholar
• Scalabrino G. Vitamin-regulated cytokines and growth factors in the CNS and elsewhere. J. Neurochem.111(6), 1309–1326 (2009).
   PubMed Web of Science ®Google Scholar
• Lionetti P, Callegari ML, Ferrari S et al. Enteral nutrition and microflora in pediatric Crohn’s disease. J. Parenter. Enteral. Nutr.29(4), S173–S175; discussion S175–S178 (2005).
   PubMed Web of Science ®Google Scholar
• Jones JL, Foxx-Orenstein AE. The role of probiotics in inflammatory bowel disease. Dig. Dis. Sci.52(3), 607–611 (2007).
   PubMed Web of Science ®Google Scholar
• Lim CC, Ferguson LR, Tannock GW. Dietary fibres as ‘prebiotics’: implications for colorectal cancer. Mol. Nutr. Food Res.49(6), 609–619 (2005).
   PubMed Web of Science ®Google Scholar
• Baines K, Wood LG, Gibson PG. The nutrigenomics of asthma: molecular mechanisms of airway neutrophilia following dietary antioxidant withdrawal. OMICS3(5), 355–365 (2009).
   Google Scholar
• Philpott M, Mackay L, Ferguson LR, Forbes D, Skinner M. Cell culture models in developing nutrigenomics foods for inflammatory bowel disease. Mutat. Res.622(1–2), 94–102 (2007).
   PubMed Web of Science ®Google Scholar
• Wang T, Dabbas B, Laperriere D et al. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin β2 innate immune pathway defective in Crohn disease. J. Biol. Chem.285, 2227–2231 (2010).
   PubMed Web of Science ®Google Scholar
• Leung CH, Lam W, Ma DL, Gullen EA, Cheng YC. Butyrate mediates nucleotide-binding and oligomerisation domain (NOD) 2-dependent mucosal immune responses against peptidoglycan. Eur. J. Immunol.39(12), 3529–3537 (2009).
   PubMed Web of Science ®Google Scholar
• Borthakur A, Bhattacharyya S, Dudeja PK, Tobacman JK. Carrageenan induces interleukin-8 production through distinct Bcl10 pathway in normal human colonic epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol.292(3), G829–G838 (2007).
   PubMed Web of Science ®Google Scholar
• Cukovic-Cavka S, Likic R, Francetic I, Rustemovic N, Opacic M, Vucelic B. Lactobacillus acidophilus as a cause of liver abscess in a NOD2/CARD15-positive patient with Crohn’s disease. Digestion73(2–3), 107–110 (2006).
   PubMed Web of Science ®Google Scholar
• Sadeghi K, Wessner B, Laggner U et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur. J. Immunol.36(2), 361–370 (2006).
   PubMed Web of Science ®Google Scholar
• Simmons JD, Mullighan C, Welsh KI, Jewell DP. Vitamin D receptor gene polymorphism: association with Crohn’s disease susceptibility. Gut47(2), 211–214 (2000).
   PubMed Web of Science ®Google Scholar
• Martin K, Radlmayr M, Borchers R, Heinzlmann M, Folwaczny C. Candidate genes colocalized to linkage regions in inflammatory bowel disease. Digestion66(2), 121–126 (2002).
   PubMed Web of Science ®Google Scholar
• Kadowaki M, Karim, MR, Carpi A, Miotto G. Nutrient control of macroautophagy in mammalian cells. Mol. Aspects Med.27(5–6), 426–443 (2006).
   PubMedGoogle Scholar
• Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, Elazar Z. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J.26(7), 1749–1760 (2007).
   PubMed Web of Science ®Google Scholar
• Gossner G, Choi M, Tan L et al. Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells. Gynecol. Oncol.105(1), 23–30 (2007).
   PubMed Web of Science ®Google Scholar
• Hazan R, Levine A, Abeliovich H. Benzoic acid, a weak organic acid food preservative, exerts specific effects on intracellular membrane trafficking pathways in Saccharomyces cerevisiae. Appl. Environ. Microbiol.70(8), 4449–4457 (2004).
   PubMed Web of Science ®Google Scholar
• Onodera J, Ohsumi Y. Autophagy is required for maintenance of amino acid levels and protein synthesis under nitrogen starvation. J. Biol. Chem.280(36), 31582–31586 (2005).
   PubMed Web of Science ®Google Scholar
• Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn’s disease. Cochrane Database Syst. Rev.24(1), CD000542 (2007).
   Google Scholar
• Kim J, Yoon M, Jie C. Signal transducer and activator of transcription 3 (STAT3) mediates amino acid inhibition of insulin signalling through serine 727 phosphorylation. J. Biol. Chem.284(51), 35425–35432 (2009).
   PubMedGoogle Scholar
• Xie L, Li XK, Funeshima-Fuji N et al. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production. Int. Immunopharmacol.9(5), 575–581 (2009).
   PubMed Web of Science ®Google Scholar
• Danesi F, Philpott M, Huebner C, Bordoni A, Ferguson LR. Food-derived bioactives as potential regulators of the IL-12/IL-23 pathway implicated in inflammatory bowel diseases. Mutat. Res. DOI: 10.1016/j.mrfmmm.2010.01.001 (2010) (In Press).
   Google Scholar
• Guerreiro CS, Ferreira P, Tavares L et al. Fatty acids, IL6, and TNFα polymorphisms: an example of nutrigenetics in Crohn’s disease. Am. J. Gastroenterol.104(9), 2241–2249 (2009).
   PubMedGoogle Scholar
• Fontaine-Bisson B, El-Sohemy A. Genetic polymorphisms of tumor necrosis factor-α modify the association between dietary polyunsaturated fatty acids and plasma high-density lipoprotein-cholesterol concentrations in a population of young adults. J. Nutrigenet. Nutrigenomics1(5), 215–223 (2008).
   PubMedGoogle Scholar
• Castagnini C, Luceri C, Toti S et al. Reduction of colonic inflammation in HLA-B27 transgenic rats by feeding Marie Ménard apples, rich in polyphenols. Br. J. Nutr.102(11), 1620–1628 (2009).
   PubMed Web of Science ®Google Scholar
• Kimchi-Sarfaty C, Oh JM, Kim IW et al. A ‘silent’ polymorphism in the MDR1 gene changes substrate specificity. Science315(5811), 525–528 (2007).
   PubMed Web of Science ®Google Scholar
• Ferguson LR, De Flora S. Multiple drug resistance, antimutagenesis and anticarcinogenesis. Mutat. Res.591(1–2), 24–33 (2005).
   PubMed Web of Science ®Google Scholar
• Nones K, Dommels YE, Martell S et al. The effects of dietary curcumin and rutin on colonic inflammation and gene expression in multidrug resistance gene-deficient (mdr1a-/-) mice, a model of inflammatory bowel diseases. Br. J. Nutr.101(2), 169–181 (2009).
   PubMed Web of Science ®Google Scholar
• Roy N, Barnett M, Knoch B, Dommels Y, McNabb W. Nutrigenomics applied to an animal model of inflammatory bowel diseases: transcriptomic analysis of the effects of eicosapentaenoic acid- and arachidonic acid-enriched diets. Mutation Res.622(1–2), 103–116 (2007).
   PubMedGoogle Scholar
• Kornman K, Rogus J, Roh-Schmidt H et al. Interleukin-1 genotype-selective inhibition of inflammatory mediators by a botanical: a nutrigenetics proof of concept. Nutrition23, 844–852 (2007).
   PubMedGoogle Scholar
• Feuk L. Inversion variants in the human genome: role in disease and genome architecture. Genome Med.2(2), 11 (2010).
   PubMedGoogle Scholar
• Stankiewicz P, Lupski JR. Structural variation in the human genome and its role in disease. Annu. Rev. Med.61, 437–455 (2010).
   PubMed Web of Science ®Google Scholar
• Dalca AV, Brudno M. Genome variation discovery with high-throughput sequencing data. Brief Bioinform.11(1), 3–14 (2010).
   PubMedGoogle Scholar
• Eleftherohorinou H, Wright V, Hoggart C et al. Pathway analysis of GWAS provides new insights into genetic susceptibility to 3 inflammatory diseases. PLoS One4(11), e8068 (2009).
   PubMedGoogle Scholar
• Lin HM, Barnett M, Roy N et al. Metabolomic analysis identifies inflammatory and non-inflammatory metabolic effects of genetic modification in a mouse model of Crohn’s disease. J. Proteome Res.9(4), 1965–1975 (2010).
   PubMed Web of Science ®Google Scholar